Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
1999-06-11
2002-08-20
Chin, Christopher L. (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S004000, C435S005000, C435S007800, C435S007100, C435S007210, C435S006120, C435S018000, C435S029000, C435S034000, C435S038000, C435S039000, C435S188000, C435S805000, C435S810000, C436S065000, C436S088000, C436S170000, C436S529000, C436S530000, C436S531000, C436S526000, C436S527000, C436S535000, C436S510000, C436S814000, C422S051000, C422S067000
Reexamination Certificate
active
06436649
ABSTRACT:
FIELD OF THE INVENTION
The present invention relates to a method for detecting and/or quantifying a hapten in a homogeneous phase, as well as the device for detection and/or quantification, in particular the kit allowing the screening and/or the assay of a hapten in a homogeneous phase.
BACKGROUND
During the past few years, major advances in the field of biotechnology have made it possible to develop immunoassays allowing the assay of haptens in a homogeneous phase, that is to say of small-sized molecules of natural origin or which are obtained by the synthetic route and which are used in particular for treating animals or humans.
Such molecules may be, for example, active components of medicaments, hormones, anabolic steroids and the like.
To facilitate the application of the tests for screening and/or assaying these haptens, attempts have been made to develop immunoassays which can be used in a homogeneous phase.
Enzymatic immunoassays have thus been proposed. They are “substrate labelled fluorescent immunoassay”, “apoenzyme reactivation immunoassay system”, “enzyme multiplied immunoassay test” and “enzyme channeling immunoassay” described by Voller and Bidwell (Voller A., Bidwell D. W., in Alternative Immunoassays, Collins W P Ed. John Wiley, Chichester, pp. 78-79 (1986)) as well as the cloned enzyme donor immunoassay (Henderson et al., Cli. Chem., 32, 9, pp. 1637-1641 (1986)).
Patent Application EP-0117648 describes an immunoassay of steroids in phase based on the inhibition of the clotting of milk, this assay giving information on the fertility of milk-producing domestic animals.
However, to date, no success has been achieved in developing, immunoassays working in a homogeneous phase which are sufficiently sensitive, specific and reproducible to allow their widespread use in the assay and/or detection of a large number of haptens in clinical biology and in various media (blood, urine and the like).
The iodine-based systems used up until now have the disadvantage that practically all iodides are oxidizable in the air, generating iodine which is lost by sublimation. This therefore constitutes a first source of instability. Moreover, starch paste is easily degraded by bacteria or fungi, which constitutes another source of instability.
Patent Application FR-2,339,172 describes a reactive system for determining if uric acid or another material oxidizable by iodine exists in a liquid in a proportion greater than a predetermined quantity in an alkaline medium, said reagent comprising a water-activatable iodine generator capable of liberating in situ an appropriate quantity of free iodine with an indicator to detect the presence of iodine. The iodine generator and the indicator are applied to a test strip. Consequently, such a device only works in the dry state and therefore remains dependent on an analysis on a solid system.
SUMMARY OF THE INVENTION
The present invention aims to obtain a method and a device for screening and/or assaying a hapten in any type of homogeneous phase (blood, serum, urine, milk and the like) which are sufficiently sensitive, specific and reproducible.
In particular, it is sought to obtain a method and a device which make it possible in particular to detect haptens present in a human or animal physiological fluid, at concentrations of the order of 100 pM or higher, or even at concentrations of the order of 10 pM or higher.
A specific aim of the present invention seeks to optimize the sensitivity of said method and device by reducing the “background noise” observed in the devices and methods of the state of the art.
A final aim of the present invention seeks to obtain a device which would be capable of being stored for a longer period without contamination or degradation.
REFERENCES:
patent: 4764462 (1988-08-01), Bredehorst et al.
patent: 5876944 (1999-03-01), Kuo
patent: 850647 (1977-07-01), None
patent: 0 117 648 (1984-09-01), None
patent: 532 187 (1993-03-01), None
patent: 0 532 187 (1993-03-01), None
patent: 0 532 187 (1993-03-01), None
Degand et al., “Enzyme immunoassay screening procedure for the sythetic anabolic estrogens and androgens diethylstilbestrol, nortestosterone, methyltestosterone and trenbolone in bovine urine.” Journal of Chromatography, 489, 1989, pp. 235-243, 1989.*
Normark et al., “Chromosal beta-lactam resistance in enterobacteria.” Scand. J. Infect. Dis., Suppl. (1986), 49 (IInt. Symp. Ecol. Impacts Antibact. Agents), 38-45 Abstract Only, 1986.*
Takesue et al., “Beta lactamase in gram-negative rods the relationship between penicillinase and R plasmids in gram-negative rods.” Hiroshima Journal of Medical Science, (1990) (3),65-70 Abstract Onily.*
Labia et al., “Kinetic studies of beta-lactamase by computerized microacidimetric method.”, Biochimica et Biophysica Acta, 384, 1975, 242-249.*
Labia et al., “Kinetic studies of beta-lactamase by computerized microacidimetric method.”, Biochimica et Biophysica Acta, 384, 1975, 242-249.*
Degand et al., “Enzyme Immunoassay Screening procedure for the synthetic anabolic estrogens and androgens diethylstilbestrol . . . ” Journal of Chromatogrphy, 489 (1989) pp. 235-243.*
Normark et al., “Chromosomal beta-lactam resistance in enterobacteria.” Scandanavian Journal of Infection, Dis., Suppl. (19860, 49 (int. Symp. Ecol. Impacts Antibact. Agents), pp. 38-45, Abstract Only.*
Takesus et al., Beta lactamase in gram-negative rods the relationship between pencillinase and r plasmids in gram-negative rods. Hiroshima Journal of Medical Science (1990) 39(3) pp. 65-70, Abstract Only.*
Labia et al., “kinetic studies of a beta-lactamase by a computerized microacidmetric method.” Biochimica et Biophysica Acta, 384 (1975) pp. 242-249.*
Wouters et al., “Expression, purification, crystallization and preliminary X-ray analysis of the native class C &bgr;-lactamase fromEnterobacter cloacae908R and two mutants,”Acta. Cryst.D57: 162-164 (2001).
Oefner et al., “Refined crystal structure of &bgr;-lactamase fromCitrobacter freundiiindicates a mechanism for &bgr;-lactam hydrolysis,”Nature, 343: 284-288 (Jan. 1990).
Lobkovsky et al., “Evolution of an enzyme activity: crystallographic structure at 2-Å resolution of cephalosporinase from the ampC gene ofEnterobacter cloacaeP99 and comparison with a class A penicillinase,”Proc. Natl. Acad. Sci. USA, 90: 11257-11261 (Dec. 1993).
Edlund et al., “Isolation and characterization of DNA repetitions carrying the chromosomal &bgr;-lactamase gene ofEscherichia coliK-12,”Molec. gen. Genet., 173: 115-125 (1979).
Voller et al., ‘Enzyme Immunoassays,’Alternative Immunoassays, pp. 77-86 (1985).
Henderson et al., ‘CEDIA, a New Homogeneous Immunoassay System,’Clinical Chemistry, vol. 32, No. 9, pp. 1637-1641 (1986).
Ghitti Gianangelo
Kohl Michel
Lejeune Robert
Renotte Roger
Sarlet Guy
Chin Christopher L.
Cook Lisa V
Le Region Wallone
Merchant & Gould P.C.
LandOfFree
Method for detecting and/or quantifying a hapten in a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for detecting and/or quantifying a hapten in a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for detecting and/or quantifying a hapten in a... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2968704